How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions

被引:36
作者
Gianchecchi, Elena [1 ]
Manenti, Alessandro [1 ,2 ]
Kistner, Otfried [1 ]
Trombetta, Claudia [3 ]
Manini, Ilaria [3 ]
Montomoli, Emanuele [1 ,2 ,3 ]
机构
[1] VisMederi Srl, Str Petriccio & Belriguardo 35, I-53100 Siena, Italy
[2] VisMederi Res Srl, Siena, Italy
[3] Univ Siena, Dept Mol & Dev Med, Siena, Italy
关键词
enzyme-linked immunosorbent assay; influenza vaccines; influenza virus; mucosal immunity; secretory IgAs; A VIRUS-INFECTION; RESPIRATORY-TRACT; IMMUNE-RESPONSE; IGA ANTIBODIES; MONOMERIC IGA; SECRETORY IGA; HETEROSUBTYPIC IMMUNITY; INTRANASAL VACCINATION; CELL RESPONSES; B-CELL;
D O I
10.1111/irv.12664
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Secretory IgAs (sIgA) constitute the principal isotype of antibodies present in nasal and mucosal secretions. They are secreted by plasma cells adjacent to the mucosal epithelial cells, the site where infection occurs, and are the main humoral mediator of mucosal immunity. Mucosally delivered vaccines, such as live attenuated influenza vaccine (LAIV), are able to mimic natural infection without causing disease or virus transmission and mainly elicit a local immune response. The measurement of sIgA concentrations in nasal swab/wash and saliva samples is therefore a valuable tool for evaluating their role in the effectiveness of such vaccines. Here, we describe two standardized assays (enzyme-linked immunosorbent assay and microneutralization) available for the quantification of sIgA and discuss the advantages and limitations of their use.
引用
收藏
页码:429 / 437
页数:9
相关论文
共 89 条
[1]  
ADA GL, 1986, CURR TOP MICROBIOL, V128, P1
[2]   Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults [J].
Ainai, Akira ;
Tamura, Shin-ichi ;
Suzuki, Tadaki ;
van Riet, Elly ;
Ito, Ryo ;
Odagiri, Takato ;
Tashiro, Masato ;
Kurata, Takeshi ;
Hasegawa, Hideki .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (09) :1962-1970
[3]   NEUTRALIZATION OF INFLUENZA-VIRUS BY LOW CONCENTRATIONS OF HEMAGGLUTININ-SPECIFIC POLYMERIC IMMUNOGLOBULIN-A INHIBITS VIRAL FUSION ACTIVITY, BUT ACTIVATION OF THE RIBONUCLEOPROTEIN IS ALSO INHIBITED [J].
ARMSTRONG, SJ ;
DIMMOCK, NJ .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3823-3832
[4]   Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines [J].
Asahi, Y ;
Yoshikawa, T ;
Watanabe, I ;
Iwasaki, T ;
Hasegawa, H ;
Sato, Y ;
Shimada, S ;
Nanno, M ;
Matsuoka, Y ;
Ohwaki, M ;
Iwakura, Y ;
Suzuki, Y ;
Aizawa, C ;
Sata, T ;
Kurata, T ;
Tamura, S .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :2930-2938
[5]   Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections [J].
Ashkenazi, Shai ;
Vertruyen, Andre ;
Aristegui, Javier ;
Esposito, Susanna ;
McKeith, David Douglas ;
Klemola, Timo ;
Biolek, Jiri ;
Kuehr, Joachim ;
Bujnowski, Tadeusz ;
Desgrandchamps, Daniel ;
Cheng, Sheau-Mei ;
Skinner, Jonathan ;
Gruber, William C. ;
Forrest, Bruce D. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) :870-879
[6]   Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults [J].
Barria, Maria Ines ;
Garrido, Jose Luis ;
Stein, Cheryl ;
Scher, Erica ;
Ge, Yongchao ;
Engel, Stephanie M. ;
Kraus, Thomas A. ;
Banach, David ;
Moran, Thomas M. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (01) :115-124
[7]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[8]   Compromised influenza virus-specific CD8+-T-Cell memory in CD4+-T-cell-deficient mice [J].
Belz, GT ;
Wodarz, D ;
Diaz, G ;
Nowak, MA ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12388-12393
[9]   Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis [J].
Beyer, WEP ;
Palache, AM ;
de Jong, JC ;
Osterhaus, ADME .
VACCINE, 2002, 20 (9-10) :1340-1353
[10]  
Brandtzaeg P, 1994, HDB MUCOSAL IMMUNOLO, P113